Spebrutinib
Product Specifications
CAS Number
1202757-89-8
Target
BTK, Src
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
Smiles
COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1
Molecular Formula
C22H22FN5O3
Molecular Weight
423.44
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A609132-10MG 10 mg
(S)-3-Amino(piperidine-3-d1)-2,6-dione hydrochloride
Sign In for Pricing
View Details 
MBS1085975 Inquire
Recombinant Drosophila melanogaster ATP synthase subunit gamma, mitochondrial (ATPsyn-gamma), partial
Sign In for Pricing
View Details TA504226S 30 µL
EXOSC7 Mouse Monoclonal Antibody [Clone ID: OTI2E5]
Sign In for Pricing
View Details 
BNC043442-100 1x 100 µL
CD81 / TAPA-1 (rC81/3442), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details bsm-62702R-Biotin-TR 20 µL
C7orf27 Recombinant Antibody, Biotin Conjugated
Sign In for Pricing
View Details